NL-OMON19917CompletedNot Applicable
Feasibility of standard therapywith temozolomide and radiotherapycombined with ketogenic dietin patients with glioblastoma multiforme
ErasmusMC0 sites12 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria part A
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •- Neurological deficit in language or cognitive functions causing inability to fully understand the study protocol and requirements
Investigators
Similar Trials
Completed
Not Applicable
Feasibility of standard therapy with temozolomide and radiotherapy combined with ketogenic diet in patients with glioblastoma multiformeGlioblastoma MultiformeNL-OMON40862Erasmus MC, Universitair Medisch Centrum Rotterdam15
Recruiting
Phase 2
Temozolomide as monotherapy for elderly and temozolomide sensitive glioblastomaglioblastomaJPRN-jRCTs031200438Tateishi Kensuke5
Active, not recruiting
Not Applicable
Chimiothérapie par Témozolomide dans le traitement des glioblastomes supratentoriels des sujets de 70 ans et plus présentant un état fonctionnel altéré (IK<70). - TAGPatients de 70 ans et plus atteints de glioblastomes supratentoriels et présentant un état fonctionnel altéré.MedDRA version: 8.1Level: PTClassification code 10018336Term: glioblastomeEUCTR2006-005549-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Completed
Not Applicable
Phase II study of Temozolomide monotheraphy in patients with first line treatment-refractory neuroendocrine carcinomaeuroendocrine carcinoma (Grade3)JPRN-UMIN000010549Yokohama City University Hospital13
Active, not recruiting
Phase 1
A Phase 2 study of temozolomide (SCH 52365) in Subjects with Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-guanine-DNA Methyltransferase (MGMT) PromoterAdvanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head and Neck (H&N), Esophageal CancerMedDRA version: 8.1 Level: LLT Classification code 10028980 Term: NeoplasmEUCTR2006-003169-15-CZSchering Plough Research Institute160